AllPennyStocks.com Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive

IBRX and SLS align with Big Pharma’s cancer push, fueling retail partnership and buyout speculation.

Other Penny Stock Movers

When Design Thinking Meets the AI Canvas
Strategic Gold Asset Sale Sends Junior Miner Sharply Higher
A $14.5 Million Exit Completes a Two-Year Retreat
Most Popular
{{ index + 1 }}


Back to Top